ZoomMed Inc (ZMD) - Financial and Strategic SWOT Analysis Review

 

Get this Report



PayPal Verified Vendor

Rating

4.2 Star Rating for report ZoomMed Inc (ZMD) - Financial and Strategic SWOT Analysis Review
4.2 / 5 stars rating
Pages: 25
Price: $300.00

Some of our Clients

Some Research and Expert Clients

Abstract

 
This comprehensive SWOT profile of ZoomMed Inc provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of ZoomMed Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
 

Description

ZoomMed Inc (ZoomMed) is a technical service provider that offers web solutions for medical sectors. The company's product includes ZoomMed Network, ZRx Prescriber, PraxisLab, and EvPsych. It builds and operates a clinical information exchange platform between physicians and specialists, patients, and others. ZoomMed's PraxisLab, a cloud-based, secure and intuitive application enhances patients' services, assists the work of the personnel and simplifies team work in the pharmacy. Its ZRx cloud-based prescriber solution analyzes each user's prescribing pattern and displays the medication, and its pre-emptive features enable physicians to write legible and secure prescription faster than a pen. ZoomMed is headquartered in Brossard, Quebec, Canada. 

Similar Reports

Other reports that may be of interest...

Report... 05IC-GDPH233681FSAEnWave Corp (ENW) - Financial and Strategic SWOT Analysis ReviewFeb 2017
Report... 05IC-GDPH61222FSAAptose Biosciences Inc (APTO) - Financial and Strategic SWOT Ana...Jul 2017
Report... 05IC-GDPH6309SAApotex Inc - Strategic SWOT Analysis ReviewJan 2017
Report... 05IK-FCB7B605-BD92-42AB-A0F4-6DValeant Pharmaceuticals International, Inc. - Strategy, SWOT and...Feb 2017
Report... 05IK-E5816C72-7C19-4440-A7B4-8FSurgical Specialties Corporation, Inc. - Strategy, SWOT and Corp...Jan 2017
Report... 05IC-GDPH4335FSAArbutus Biopharma Corporation (ABUS) - Financial and Strategic S...Oct 2016
Report... 05IC-GDPH188788SAAlberta Health Services - Strategic SWOT Analysis ReviewOct 2016
Report... 05IC-GDPH511336FSAKnight Therapeutics Inc (GUD) - Financial and Strategic SWOT Ana...Aug 2017
Report... 05IC-GDPH140544FSAIntellipharmaceutics International Inc (I) - Financial and Strat...Aug 2017
Report... 05IC-GDPH82106FSAMedical Facilities Corp (DR) - Financial and Strategic SWOT Anal...Aug 2017

Report Source Information

Supplied by: Research and Experts 
Date Published: 2017-08-07 

Report: ZoomMed Inc (ZMD) - Financial and Strategic SWOT Analysis Review

 

Contents

Table of Contents

Section 1 - About the Company

ZoomMed Inc - Key Information
ZoomMed Inc - Overview
ZoomMed Inc - Key Employees
ZoomMed Inc - Key Employee Biographies
ZoomMed Inc - Key Operational Heads
ZoomMed Inc - Major Products and Services
ZoomMed Inc - History
ZoomMed Inc - Company Statement
ZoomMed Inc - Locations And Subsidiaries
ZoomMed Inc - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

ZoomMed Inc - Business Description
ZoomMed Inc - Corporate Strategy
ZoomMed Inc - SWOT Analysis
SWOT Analysis - Overview
ZoomMed Inc - Strengths
ZoomMed Inc - Weaknesses
ZoomMed Inc - Opportunities
ZoomMed Inc - Threats
ZoomMed Inc - Key Competitors

Section 3 - Company Financial Performance Charts

ZoomMed Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company
 

List of Tables

List of Tables

ZoomMed Inc, Key Information
ZoomMed Inc, Key Ratios
ZoomMed Inc, Share Data
ZoomMed Inc, Major Products and Services
ZoomMed Inc, History
ZoomMed Inc, Key Employees
ZoomMed Inc, Key Employee Biographies
ZoomMed Inc, Key Operational Heads
ZoomMed Inc, Other Locations
ZoomMed Inc, Subsidiaries
ZoomMed Inc, Key Manufacturing facilities
ZoomMed Inc, Key Competitors
ZoomMed Inc, SWOT Analysis
ZoomMed Inc, Ratios based on current share price
ZoomMed Inc, Annual Ratios
ZoomMed Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 

List of Figures

List of Figures

ZoomMed Inc, Performance Chart
ZoomMed Inc, Ratio Charts
 

Scope

The profile contains critical company information including*,

- Business description - A detailed description of the company's operations and business divisions.
- Corporate strategy - Analyst's summarization of the company's business strategy.
- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

 

Classification

Language Code: EN 
Region: Canada 
Report Type: Company Reports 
Industry: Life Sciences 
Sector: Life Sciences 
Pages: 25 

Reasons to buy this report

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
 

Similar Reports

Other reports that may be of interest...

Report... 05IC-GDPH233681FSAEnWave Corp (ENW) - Financial and Strategic SWOT Analysis ReviewFeb 2017
Report... 05IC-GDPH61222FSAAptose Biosciences Inc (APTO) - Financial and Strategic SWOT Ana...Jul 2017
Report... 05IC-GDPH6309SAApotex Inc - Strategic SWOT Analysis ReviewJan 2017
Report... 05IK-FCB7B605-BD92-42AB-A0F4-6DValeant Pharmaceuticals International, Inc. - Strategy, SWOT and...Feb 2017
Report... 05IK-E5816C72-7C19-4440-A7B4-8FSurgical Specialties Corporation, Inc. - Strategy, SWOT and Corp...Jan 2017
Report... 05IC-GDPH4335FSAArbutus Biopharma Corporation (ABUS) - Financial and Strategic S...Oct 2016
Report... 05IC-GDPH188788SAAlberta Health Services - Strategic SWOT Analysis ReviewOct 2016
Report... 05IC-GDPH511336FSAKnight Therapeutics Inc (GUD) - Financial and Strategic SWOT Ana...Aug 2017
Report... 05IC-GDPH140544FSAIntellipharmaceutics International Inc (I) - Financial and Strat...Aug 2017
Report... 05IC-GDPH82106FSAMedical Facilities Corp (DR) - Financial and Strategic SWOT Anal...Aug 2017

ZoomMed Inc (ZMD) - Financial and Strategic SWOT Analysis Review

Report 05IC-GDPH7138FSA has a rating of 84 percent
Figure of merit assessment for report 05IC-GDPH7138FSA

Relevance Rating

The Research and Experts relevance ranting consists of a set of figure of merit (FOM) values that are provided as an indication of the value of the report in the current economic environment.

These FOM values cannot take into account the reason for the clients interest in a report and therefore the client should view these FOM values only as a visual guide. The FOM scores are based on

market interest - how often the report is viewed or purchased,
elapsed time - time since the report was published,
report detail - amount of detail in the report (pages, figures, images, comments etc.) and
price - the price of the report.


Regional Information

Taxonomy

Branch ID: 1369

Taxonomy Location

The taxonomy on the left shows the ancestors of the Canada node. This provides an insight into parent categories that may provide reports or articles that may compliment this report. The number in brackets after the node name indicates the number of reports that Research and Experts currently have in the parent category.

Clicking on a parent category will present the list of reports in the parent node in a separate window.

Canada

Canada is one of the leading economies of the world. Key industries are oil, logging, fisheries, manufacturing and a growing software sector. The services sector accounts for over 75% of all employment. 

GDP for 2013 was 2.9% with estimated growth increasing to 3.4% and 3.7% in 2014 and 2015. Canada's growth in 2013 was helped by US GDP growth and an increase in mining, quarrying and utilities. Unemployment is currently at 7.2%.

Main imports include machinery and equipment, motor vehicles and parts, crude oil, chemicals, electricity, durable consumer goods.  

Researchandexperts.com is a  leading source of market research on Canada.

Useful Links

OECD overview of Canada

Canada and the IMF

Canada

Northern America

Region

 

North America

The term North America usually refers to the US and Canada sometimes including Geenland, Mexico and the islands of Bermuda, St Helena and Saint Pierre et Miquelon.  

North America is dominated by the largest global economy, the United States. The main industries in the US are technology, petroleum, steel, motor vehicles, aerospace, telecommunications, chemicals, electronics, food processing, consumer goods, lumber and mining. The US main tading partners are Canada, China, Mexico, Japan, and Germany. Canada is one of the largest economies in the world and is listed as one of the G8. Canada has a well established services sector along with well established industries in the areas of maufacturing, mining and logging. Canada's main trading partners are US, EU, China and Mexico.

 Research and Experts, the market intelligence platform, provides companies with access to the latest leading industry reports covering the North American region. Our company reports contain the following information; company overviews, key facts, key employees, products and services, as well as financial ratios. Our industry reports are vital sources of detailed historic and forecast values for markets in North America, segmented at category level.

Research and Experts reports also provide regional analysis and analysis of the leading companies in key North American markets.  Researchandexperts.com is a  leading source of market research on North America.

North America

Country

Countries

 

Industry Sector Information

Taxonomy

Branch ID: 205

Taxonomy Location

The taxonomy on the left shows the ancestors of the Life Sciences node. This provides an insight into parent categories that may provide reports or articles that may compliment this report. The number in brackets after the node name indicates the number of reports that Research and Experts currently have in the parent category.

Clicking on a parent category will present the list of reports in the parent node in a separate window.

Life Sciences

The Life Sciences industry includes biotechnology, healthcare, pharmaceuticals, medical devices and diagnostics. The industry is dominated by US companies requiring considerable investment in research and development to stay competitive.  While US companies dominate this space, competition is emerging from smaller companies in Europe and Asia. 

Companies trying to stay competitive or enter new markets in life sciences consult our reports. For example, Plimsoll, in their recent review of global antibiotic manufacturers have reviewed 150 of the largest manufacturers including analysis of  ANTIBIOTICE SA, BAYER HEALTHCARE MANUFACTURING SRL and CIPLA LTD. 

Our reports are a requirement for companies looking for the best competitive intelligence in the life sciences sector providing information on market size, rankings, best trading partners and financial analysis. 

Useful Links

Analytical Life Sciences and Diagnostics Association

German Life Sciences Association

 

Life Sciences

Industry

Industries

 

 

Buy: ZoomMed Inc (ZMD) - Financial and Strategic SWOT Analysis Review

 

Item Code: 05IC-GDPH7138FSA

 
Licence: Single User
Price: $300.00
 
VAT: 0.0% 
Total: $300.00 

Feedback

Return to Research and Experts

Page created and rendered - Cache updated [1.50970s]

--